C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/52 (2006.01) A61K 31/47 (2006.01) A61P 3/04 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2611060
Compounds of Formula I wherein R1, A, R2, n, R3, m, R5 and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
L'invention concerne des composés représentés par la formule (I) dans laquelle R1, A, R2, n, R3, m, R5 et q sont tels que décrits dans la spécification, des sels pharmaceutiquement acceptables, des procédés de production, des compositions pharmaceutiques contenant lesdits composés et des méthodes d'utilisation de ces composés.
Albert S. Jeffrey
Alhambra Cristobal
Kang James
Koether M. Gerard
Li Yan
Astrazeneca Ab
Mccarthy Tetrault Llp
LandOfFree
Quinoline derivatives as nk3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as nk3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as nk3 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1438513